REGN Insider Transactions — Page 23
4,472 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 2,201–2,300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| VAGELOS P ROY | Chairman of the Board | 2019-11-25 | Sale | 3,755.0 | $364.55 |
| VAGELOS P ROY | Chairman of the Board | 2019-11-25 | Sale | 3,605.0 | $363.53 |
| VAGELOS P ROY | Chairman of the Board | 2019-11-25 | Sale | 2,284.0 | $362.61 |
| VAGELOS P ROY | Chairman of the Board | 2019-11-25 | Sale | 2,492.0 | $361.46 |
| VAGELOS P ROY | Chairman of the Board | 2019-11-25 | Sale | 592.0 | $360.37 |
| VAGELOS P ROY | Chairman of the Board | 2019-11-25 | Sale | 1,479.0 | $359.46 |
| VAGELOS P ROY | Chairman of the Board | 2019-11-25 | Sale | 156.0 | $358.92 |
| GOLDSTEIN JOSEPH L | Director | 2019-11-22 | Sale | 1,000.0 | $360.0 |
| GOLDSTEIN JOSEPH L | Director | 2019-11-21 | Sale | 1,000.0 | $350.0 |
| BROWN MICHAEL S | Director | 2019-11-12 | Sale | 4,500.0 | $349.0 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 300.0 | $341.38 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 2,064.0 | $340.48 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 1,100.0 | $339.53 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 1,100.0 | $338.54 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 1,500.0 | $337.41 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 500.0 | $336.73 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 400.0 | $335.45 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 100.0 | $334.66 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 200.0 | $333.32 |
| STAHL NEIL | EVP Research and Development | 2019-11-08 | Sale | 100.0 | $330.56 |
| GOLDSTEIN JOSEPH L | Director | 2019-11-08 | Sale | 1,000.0 | $340.44 |
| Sanofi | TenPercentOwner | 2019-09-10 | Sale | 172,904.0 | $281.15 |
| GOLDSTEIN JOSEPH L | Director | 2019-05-15 | Sale | 1,000.0 | $305.93 |
| STAHL NEIL | EVP Research and Development | 2019-05-14 | Sale | 3,278.0 | $306.37 |
| STAHL NEIL | EVP Research and Development | 2019-05-14 | Sale | 6,575.0 | $305.43 |
| Sanofi | TenPercentOwner | 2019-03-08 | Sale | 131,115.0 | $412.17 |
| GOLDSTEIN JOSEPH L | Director | 2019-01-10 | Sale | 1,791.0 | $410.0 |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | Sale | 200.0 | $362.45 |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | Sale | 100.0 | $361.65 |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | Sale | 500.0 | $360.4 |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | Sale | 200.0 | $359.38 |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | Sale | 200.0 | $358.27 |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | Sale | 200.0 | $357.5 |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | Sale | 348.0 | $356.27 |
| Fenimore Christopher R. | VP Controller | 2018-12-20 | Sale | 100.0 | $355.14 |
| VAGELOS P ROY | Chairman of the Board | 2018-12-12 | Sale | 6.0 | $382.32 |
| GOLDSTEIN JOSEPH L | Director | 2018-09-28 | Sale | 709.0 | $410.0 |
| GOLDSTEIN JOSEPH L | Director | 2018-09-27 | Sale | 2,000.0 | $400.0 |
| BROWN MICHAEL S | Director | 2018-09-27 | Sale | 260.0 | $395.42 |
| BROWN MICHAEL S | Director | 2018-09-27 | Sale | 40.0 | $394.43 |
| BROWN MICHAEL S | Director | 2018-09-27 | Sale | 300.0 | $393.49 |
| BROWN MICHAEL S | Director | 2018-09-27 | Sale | 410.0 | $392.37 |
| BROWN MICHAEL S | Director | 2018-09-27 | Sale | 601.0 | $391.38 |
| BROWN MICHAEL S | Director | 2018-09-27 | Sale | 389.0 | $390.23 |
| GOLDSTEIN JOSEPH L | Director | 2018-09-24 | Sale | 1,000.0 | $387.29 |
| GOLDSTEIN JOSEPH L | Director | 2018-09-24 | Sale | 1,000.0 | $390.0 |
| Sanofi | TenPercentOwner | 2018-09-06 | Sale | 104,552.0 | $406.68 |
| BROWN MICHAEL S | Director | 2018-08-22 | Sale | 1,500.0 | $380.49 |
| GOLDSTEIN JOSEPH L | Director | 2018-08-02 | Sale | 2,000.0 | $380.0 |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | Sale | 300.0 | $371.29 |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | Sale | 100.0 | $370.17 |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | Sale | 13,194.0 | $369.41 |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | Sale | 12,211.0 | $368.61 |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | Sale | 6,405.0 | $367.4 |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | Sale | 24,339.0 | $366.49 |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | Sale | 17,221.0 | $365.56 |
| VAGELOS P ROY | Chairman of the Board | 2018-07-10 | Sale | 900.0 | $364.75 |
| GOLDSTEIN JOSEPH L | Director | 2018-07-06 | Sale | 2,000.0 | $370.0 |
| GOLDSTEIN JOSEPH L | Director | 2018-07-05 | Sale | 2,000.0 | $360.0 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 200.0 | $336.87 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 300.0 | $335.01 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 500.0 | $333.15 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 1,300.0 | $332.8 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 100.0 | $331.09 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 3,096.0 | $330.32 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 12,854.0 | $329.51 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 12,426.0 | $328.45 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 19,393.0 | $327.48 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 15,594.0 | $326.57 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 8,047.0 | $325.67 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 500.0 | $324.18 |
| VAGELOS P ROY | Chairman of the Board | 2018-06-21 | Sale | 400.0 | $323.97 |
| Sanofi | TenPercentOwner | 2018-06-08 | Sale | 121,601.0 | $309.31 |
| STAHL NEIL | EVP Research and Development | 2018-05-24 | Sale | 11,407.0 | $295.09 |
| SING GEORGE L | Director | 2018-05-10 | Sale | 4,000.0 | $288.0 |
| SING GEORGE L | Director | 2018-05-10 | Sale | 3,000.0 | $287.0 |
| SING GEORGE L | Director | 2018-05-10 | Sale | 3,000.0 | $286.0 |
| SING GEORGE L | Director | 2018-05-10 | Sale | 3,000.0 | $285.0 |
| SING GEORGE L | Director | 2018-05-09 | Sale | 7,000.0 | $285.29 |
| GOLDSTEIN JOSEPH L | Director | 2018-03-19 | Sale | 2,000.0 | $350.02 |
| GOLDSTEIN JOSEPH L | Director | 2018-03-14 | Sale | 2,000.0 | $340.0 |
| GOLDSTEIN JOSEPH L | Director | 2018-02-09 | Sale | 1,000.0 | $325.6 |
| BROWN MICHAEL S | Director | 2017-10-05 | Sale | 1,500.0 | $475.0 |
| BAKER CHARLES A | Director | 2017-09-29 | Sale | 2,000.0 | $450.0 |
| Landry Robert E | SVP Finance & CFO | 2017-09-06 | Sale | 100.0 | $499.69 |
| Landry Robert E | SVP Finance & CFO | 2017-09-06 | Sale | 100.0 | $498.25 |
| Landry Robert E | SVP Finance & CFO | 2017-09-06 | Sale | 100.0 | $496.86 |
| Landry Robert E | SVP Finance & CFO | 2017-09-06 | Sale | 74.0 | $496.52 |
| Landry Robert E | SVP Finance & CFO | 2017-09-06 | Sale | 100.0 | $496.51 |
| Landry Robert E | SVP Finance & CFO | 2017-09-05 | Sale | 89.0 | $501.88 |
| Landry Robert E | SVP Finance & CFO | 2017-09-05 | Sale | 100.0 | $500.33 |
| Landry Robert E | SVP Finance & CFO | 2017-08-31 | Sale | 127.0 | $497.69 |
| Landry Robert E | SVP Finance & CFO | 2017-08-31 | Sale | 100.0 | $497.42 |
| Landry Robert E | SVP Finance & CFO | 2017-08-31 | Sale | 100.0 | $489.56 |
| Landry Robert E | SVP Finance & CFO | 2017-08-31 | Sale | 100.0 | $487.88 |
| Sanofi | TenPercentOwner | 2017-08-25 | Purchase | 2,557.0 | $487.01 |
| Sanofi | TenPercentOwner | 2017-08-25 | Purchase | 2,681.0 | $485.99 |
| Sanofi | TenPercentOwner | 2017-08-25 | Purchase | 5,723.0 | $485.28 |
| Sanofi | TenPercentOwner | 2017-08-25 | Purchase | 2,000.0 | $484.21 |
| Sanofi | TenPercentOwner | 2017-08-25 | Purchase | 4,485.0 | $482.87 |